7A24ICD-11 MMS 2026-01
Hypersomnia due to a medication or substance
Description
Hypersomnia due to a medication or substance is characterised by excessive nocturnal sleep, daytime sleepiness, or excessive napping that is attributable to the sedating effects of medications, alcohol, or other psychoactive substances, including withdrawal syndromes (e.g., from stimulants) and is sufficiently severe to constitute an independent focus of clinical attention. Note: A definitive diagnosis requires use of polysomnography and multiple sleep latency test (MSLT) to rule out other hypersomnolence disorders or other sleep disorders (e.g. obstructive sleep apnea) which might better explain the sleepiness.
Index terms
- Hypersomnia due to a medication or substance
- Hypersomnia due to substances including medications
- Hypersomnolence due to substances including medications
Inclusions
- Hypersomnia due to substances including medications
Sibling codes
Foundation entity
Hypersomnia due to a medication or substance – http://id.who.int/icd/entity/300740103
Allowed postcoordination axes
Part of: 07: Sleep-wake disorders